Overdiagnosis

Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis – Thanya Pathirana, et.al

2023-04-14T13:35:12+10:00Overdiagnosis, Overtesting, Overuse, Publications, Shared decision making|

Overuse is defined as provision of healthcare which is more likely to result in harm than good, and it is fast becoming a threat to human health and the sustainability of health systems worldwide. Overuse may, but not always, increase the risk of overdiagnosis, which [...]

Considering potential benefits, as well as harms, from the COVID-19 disruption to cancer screening and other healthcare services – Katy JL Bell, et.al

2024-02-11T15:19:44+11:00Breast cancer, Cancer, COVID-19, Low-value care, Overdiagnosis, Overtreatment, Prostate cancer, Publications, Screening|

Since 2020, hundreds of thousands of more deaths than expected have been observed across the globe. Amid the coronavirus 2019 (COVID-19) pandemic, current research priorities are to control the spread of infection and minimise loss of life. However, there may be future opportunities to learn [...]

Low-risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label – Caitlin R. Semsarian et al.

2023-03-01T12:28:26+11:00Cancer, Disease labels, Expanding disease definitions, Overdiagnosis, Overtreatment, Prostate cancer, Publications|

This review found robust evidence to inform discussion of possible recalibration of diagnostic thresholds, or use of alternative labels, for low-risk prostate cancer. RCTs and cohort studies demonstrate that active surveillance is a safe option for very low-risk and low-risk prostate cancers, with extremely low [...]

Computed Tomography Angiography for Detection of Pulmonary Embolism in Western Australia Shows Increasing Use with Decreasing Diagnostic Yield – David Youens et al.

2023-03-01T12:29:15+11:00Choosing Wisely, Imaging, Overdiagnosis, Overtesting, Overtreatment, Overuse, Publications|

CTPA use increased from 2005 to 2015 while diagnostic yield amongst ED patients decreased. The PE hospitalization rate also increased, while the outcome of PE mortality remained constant. Although this study cannot prove that overuse occurred, increasing CTPA use with decreasing diagnostic yield suggests an [...]

Overuse of medications in low- and middle-income countries: a scoping review – Loai Albarqouni et. al

2023-01-25T15:20:38+11:00Low-value care, Overdiagnosis, Overtreatment, Overuse, Polypharmacy, Publications|

Growing evidence suggests overuse of medications is widespread within low- and middle-income countries, across multiple drug classes, with few data of solutions from randomized trials. Opportunities exist to build collaborations to rigorously develop and evaluate potential solutions to reduce overuse of medications.

Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis – Thanya Pathirana et. al

2023-01-11T13:08:37+11:00Overdiagnosis, Overuse, Publications|

Overuse is defined as provision of healthcare which is more likely to result in harm than good, and it is fast becoming a threat to human health and the sustainability of health systems worldwide. Overuse may, but not always, increase the risk of overdiagnosis, which [...]

Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review – Loai Albarqouni et. al

2023-01-11T13:03:30+11:00Overdiagnosis, Overtesting, Publications, Screening|

Overdiagnosis and overuse of healthcare services harm individuals, take resources that could be used to address underuse, and threaten the sustainability of health systems. These problems are attracting increasing attention in low-income and middle-income countries (LMICs). Unaware of any review of relevant evidence, we conducted [...]

Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms – Rachel Farber et. al

2023-01-11T11:24:25+11:00Cancer, Overdiagnosis, Publications, Screening|

This framework focuses on the importance of the consideration of the downstream intermediate and long-term health outcomes when a change to a screening program is introduced. The authors present a methodology for utilising the relationship between screen-detected and interval cancer rates to infer the benefits [...]

Go to Top